Hampharma SRL
2.8 FTEHampharma reported total assets of €1.75m at the end of the 2024 financial year (annual accounts filed with the NBB on 28 Aug 2025), with 2.8 full-time equivalents.
The score of Hampharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +3 % Total assets +246 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hampharma's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 218,642 € | ||||
| Equity | 29,769 € | ||||
| Cash | 287,118 € | ||||
| EBITDA | 276,740 € | ||||
| Total assets | €1.75m |
Filed annual accounts
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 28 Aug 2022
- Year ended 31 Dec 2020filed on 09 Aug 2021
Hampharma's financial analysis
- Solvency1.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hampharma
Hampharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0423.277.613
- VAT number
- BE0423277613
- Peppol
- Registered · 0208:0423277613 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Jul 1982
- Registered office
- 3945 Tessenderlo-Ham
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2024 · filed on 28 Aug 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hampharma (SRL) has been based in Tessenderlo-Ham since 1982, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 218,642 € and equity of 29,769 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 1.7%, below the median of its sector (44.2%).
Companies similar to Hampharma
Companies in the same business, of comparable size and area, outside its group.
- Inge Thoelen Retail sale of pharmaceutical products Landen · balance sheet €1.74m
- Selvais Retail sale of pharmaceutical products Bastogne · balance sheet €1.75m
- Apotheek Luyten Retail sale of pharmaceutical products Nijlen · balance sheet €1.76m
- Mooy Pharma Retail sale of pharmaceutical products Veurne · balance sheet €1.74m
- Apelec Retail sale of pharmaceutical products Zemst · balance sheet €1.74m
- Den Baksteen Retail sale of pharmaceutical products Asse · balance sheet €1.73m
- Pharmacie Charue Retail sale of pharmaceutical products Fleurus · balance sheet €1.76m
- D4-Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet €1.77m
Frequently asked questions about Hampharma
What is the revenue of Hampharma?
Hampharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Hampharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0423277613 for Hampharma, if the company is VAT-registered. Its company number (CBE) is 0423.277.613.
Where is the registered office of Hampharma?
According to the CBE register, the registered office of Hampharma is in 3945 Tessenderlo-Ham.
What is the equity of Hampharma?
At the close of the 2024 financial year, the equity of Hampharma amounts to 29,769 €, a solvency of 1.7% of total assets.
How many people work at Hampharma?
2.8 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Hampharma?
The register lists 2 active mandates at Hampharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hampharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →